[1] Yim D,Curtis N,Cheung M,et al.An update on Kawasaki disease II:clinical features,diagnosis,treatment and outcomes[J].J Paediatr Child Health,2013,49(8):614-623. [2] Yim D,Curtis N,Cheung M,et al.Update on Kawasaki disease:Epidemiology,aetiology and pathogenesis[J].J Paediatr Child Health,2013,49(9):704-708. [3] Tajfard M,Latiff LA,Rahimi HR,et al.Serum inflammatory cytokines and depression in coronary artery disease[J].Iran Red Crescent Med J,2014,16(7):e17111. [4] 王卫平.儿科学[M].北京:人民卫生出版社,2013:192-194. [5] 李卓颖,韩冬,江杰,等.川崎病患儿血小板内皮细胞黏附因子-1基因373位点及1688位点基因多态性研究[J].中国循环杂志,2013,28(4):285- 288. [6] 陈碧仪,李卓颖,江杰,等.纤维蛋白原β链-148C/T和-455G/A基因多态性与川崎病的相关性[J].临床心血管病杂志,2013,29(5):387-390. [7] 史翠平,张宏艳.THFBR2 基因多态性与川崎病和冠状动脉损伤相关性的研究[J].中国当代儿科杂志,2013,15(9):767-770. [8] Lin YJ,Chang JS,Liu X,et al.Association between GRIN3A gene polymorphism in Kawasaki disease and coronary artery aneurysms in taiwanese children[J].PLoS One,2013,8(11):e81384. [9] Ononchi Y,Gunji T,Burns JC,et al.ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysnm[J].Nat Genet,2008,40:35-42. [10] Rajappa M,Goswami B,Balasubramanian A,et al.Interplay between inflammation and hemostasis in patients with coronary artery disease[J].Indian J Clin Biochem,2015,30(3):281-285. [11] Mizuno H,Sato H,Sakata Y,et al.Impact of atherosclerosis-related gene polymorphisms on mortality and recurrent events after myocardial infaretion[J].Atheroselerosis,2006,185(2):400-405. [12] Clarke R,Xu P,Bennett D,et al.Lymphotoxin-alpha gene and risk of myocardial infarction in 6,928 cases and 2,712 controls in the ISIS case-control study[J].PLoS Genet,2006;2(7):e107. |